Personal profile

Personal webpage

Biography

Raymond Schiffelers studied Bio-Pharmaceutical Sciences at Leiden University (1990-1995). After an industrial traineeship at SmithKline Beecham Pharmaceuticals (UK) he did his PhD in medical microbiology at Erasmus University Rotterdam on liposomal targeting of antimicrobial agents (1996-2001). Subsequently he became post-doc at Utrecht University working on liposomes targeting tumor vasculature. In 2002-2003, at Intradigm Co (USA) he expanded his tumor vasculature-targeting work with polymers for delivery of siRNA. After his return to Utrecht University he became assistant and then associate professor. He co-invented OncoCort® a nanomedicine formulation of corticosteroids that will enter clinical trials in 2015.  In 2011, he moved to the Laboratory for Clinical Chemistry & Hematology of the University Medical Center Utrecht to work on nanomedicines, both for diagnosis and therapy. In particularly, he focuses on extracellular vesicles in the circulation as inspiration for new drug delivery systems and diagnostic readouts. He is founding member of the International Society for Extracellular Vesicles (ISEV) founding member and member organizing committee for the ISEV2014-annual meeting, Associate Editor of the Journal Extracellular Vesicles and editor of the International Journal of Pharmaceutics and the Journal of Controlled Release. He is Founder of EXCYTEX-an extracellular vesicle-based company and member of the Scientific Advisory Board for a number of start-up companies.

 

Side activities

Without remuneration

President European Technology Platform Nanomedicine

Associate Editor Journal of Extracellular Vesicles & Drug Delivery and Translational Research

Founder/Share holder (<5%)/Scientific Advisor Excytex bv

Member Scientific Advisory Board Anjarium BioSciences

Member Scientific Advisory Board SentryX bv 

 

 

Remuneration for department

Editor International Journal Pharmaceutics

Editor Journal Controlled Release

 

Part-time employment

Nanocell Therapeutics BV

Fellowship & awards

Vidi 2007 ‘Targeting inflammation to fight cancer’

Galenus Research Award 2009

ERC Consolidator grant 2010 260627 ‘Microvesicle-inspired drug delivery systems’

ERC Proof of Concept grant 2012 29744 ‘TargetMV’

Education/Academic qualification

PhD Liposomal Targeting of Antimicrobial Agents to Bacterial Infections, Erasmus University Rotterdam

15 Jan 19967 Feb 2001

Award Date: 7 Feb 2001

MSc Bio-Pharmaceutical Sciences, Leiden University

1 Sept 198925 Sept 1995

Award Date: 25 Sept 1995

External positions

Binnen Nanocell Therapeutics heb ik de functie van VP Preclinical R&D - supervisie onderzoekers op het gebied van preklinische R&D van nanomedicines - Nanocell Therapeutics

1 Jun 202131 Dec 3999

Editor - Blad op mijn vakgebied - Journal of Controlled Release

1 Jun 202031 Dec 3999

president ETPN - strategie in europees nanomedicine onderzoek - European Technology Platform Nanomedicine

1 Jun 201931 Dec 3999

Scientific Advisory Board - bedrijf ontwikkelt producten op mijn vakgebied - SentryX bv

1 Jun 201931 Dec 3999

associate editor - publicatie op mijn vakgebied - Drug Delivery & Translational Research

1 Aug 201831 Dec 3999

Scientific Advisory Board - Bedrijf ontwikkelt nanodeeltjes - Anjarium BioSciences

1 Mar 201831 Dec 3999

editor - publicatie op mijn vakgebied - International Journal of Pharmaceutics

1 Jun 201631 Dec 3999

associate editor - blad op mijn vakgebied - Journal Extracellular Vesicles

1 Jun 201531 Dec 3999

Chief Scientific Officer - Wetenschappelijke ontwikkelingen signaleren en onderzoeksstrategie bepalen - Excytex bv

15 Jan 201431 Dec 3999

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or